nhc20190313_8k.htm

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

————————————

 

FORM 8-K

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): March 13, 2019 (March 11, 2019)

 

 

————————————

 

 

NATIONAL HEALTHCARE CORPORATION

(Exact name of registrant as specified in its charter)

 

 

————————————

 

 

Delaware

001-13489

52-2057472

(State or other jurisdiction

of incorporation)

(Commission File Number)

(I.R.S. Employer Identification No.)

 

100 Vine Street

 

 

Murfreesboro, Tennessee

 

37130

(Address of Principal Executive Offices)

 

(Zip Code)

 

 

Registrant’s telephone number, including area code: (615) 890-2020

 

Not Applicable

(Former name or former address, if changed since last report)

 

————————————

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

[   ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

[   ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

[   ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

[   ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities Exchange Act of 1934.

[   ] Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [   ]

 

 

 
 

 

Item 5.02(b)

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

 

On March 11, 2019, Julia W. Powell, an NHC partner since 1974, notified the Company that she intends to retire effective May 31, 2019.  The decision of Mrs. Powell to retire did not involve any disagreement with the Company.  Mrs. Powell is 69 years old and currently serves as NHC’s Chief Nursing Officer and Senior Vice President of Patient Services.

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Date: March 13, 2019

 

  NATIONAL HEALTHCARE CORPORATION
   
   
  By: /s/ Stephen F. Flatt
  Name: Stephen F. Flatt
  Title: Chief Executive Officer